Pierre Fabre and RedRidge Bio Partner on Biparatopic Antibody Development for Precision Oncology
France’s Pierre Fabre Laboratories has entered into a strategic partnership with Switzerland-based RedRidge Bio AG...
Deals
INTCO Medical and JD Healthcare Partner to Innovate ‘Internet + Healthcare’ Service Models
China-based INTCO Medical (SHE: 300677), a high-tech manufacturer of medical consumables and equipment, has entered...
iRegene Therapeutics Secures RMB 100 Million in Series B+ Financing to Advance iPSC Technology
Wuhan-based iRegene Therapeutics, a pioneer in AI-powered, chemically induced cell therapies, has reportedly raised close...
Nona Biosciences and Atossa Therapeutics Forge Partnership to Advance Breast Cancer Therapies
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a...
Astellas Pharma Partners with Shanghai Pharma on Zolbetuximab Commercialization
Japan-based Astellas Pharma Inc. (TYO: 4503) announced a strategic partnership with Shanghai Pharmaceuticals (SPH; SHA:...
Sinopep-Allsino Partners with Gulf Pharmaceutical for Semaglutide API Supply
Jiangsu-based Contract Development and Manufacturing Organization (CDMO) Sinopep-Allsino Biopharmaceutical Co., Ltd (SHA: 688076) has signed...
Shanghai Kehua Bioengineering Launches Xi’an Medical Complex Project
Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), a leading Chinese biotechnology company, has announced plans...
HuidaGene’s hfCas12Max Licensed to Vita Therapeutics for Neuromuscular Cell Therapy
Shanghai-based genome medicines specialist HuidaGene Therapeutics has sublicensed its hfCas12Max platform to Vita Therapeutics, Inc.,...
Aidea Pharma Terminates COVID-19 Drug Collaboration with PharmaBlock
China-based Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488) announced the termination of its development collaboration...
IDT and Shanghai Bioscience Forge Partnership to Drive Local Innovation in China
Integrated DNA Technologies (IDT), a leading life sciences and diagnostics company under the Danaher Corporation...
TJ Biopharma Partners with Biogen on Felzartamab Phase III Studies in China
China-based TJ Biopharma has entered into an agreement with US-based Biogen Inc. (NASDAQ: BIIB) to...
Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China
In alignment with China’s “Weight Management Year” initiative, Denmark-based Novo Nordisk A/S (NYSE: NVO) has...
Siemens Set to Acquire Dotmatics for $5.1 Billion to Boost Life Sciences R&D
German industrial giant Siemens AG (ETR: SIE) has announced plans to acquire US-based Dotmatics, a...
Lynmou Medical Secures Series A Funding for Endoscope Expansion
Lynmou Medical, a Hangzhou-based provider of soft endoscope solutions, has reportedly secured “tens of millions”...
Hengrui Pharmaceuticals Licenses SHR7280 to Merck for Assisted Reproduction
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has entered into a licensing agreement with...
Duality Biotherapeutics Makes Hong Kong IPO Debut with ADC Pipeline
China-based Duality Biotherapeutics, Inc. (HKG: 9606) successfully debuted in Hong Kong after completing an initial...
ABL Bio and GSK Partner on Neurodegenerative Disease Therapies with Grabody-B Platform
South Korea-based clinical-stage biotech ABL Bio Inc. (KOSDAQ: 298380) has entered into a licensing agreement...
Eli Lilly Secures Global License for Sangamo’s STAC-BBB Gene Therapy Technology
US pharmaceutical giant Eli Lilly and Company (NYSE: LLY) has entered into a licensing agreement...
Johnson & Johnson Completes Acquisition of Intra-Cellular Therapies
US-based Johnson & Johnson (NYSE: JNJ) announced the completion of its acquisition of fellow American...
Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development
Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease,...